摘要
背景Rh（-）血是一种特殊的稀有血型。Rh（-）血患者理应输注Rh（-）血，但某些特殊情况下不得不为Rh（．）血患者输注Rh（＋）血，进而可能导致同种免疫反应的发生。目前对Rh（-）血患者的临床输血管理尚存争议。目的此文旨在基于目前的研究为Rh（-）血患者临床输血管理提供切实可行的优化方案。内容此文探讨了Rh（-）血患者临床输血的相关问题、Rh（-）血患者输注红细胞的策略及包括应用自身输血与Rh免疫球蛋白在内的相应的输血管理。趋向自身输血及Rh免疫球蛋白的应用将有助于改善Rh（-）血患者临床输血管理。
Background Rh （-）blood is a scarce blood type. In certain situations, the scarcity of Rh （-）blood makes the transfusion of Rh（＋）RBCs unavoidable which could lead to alloimmunization, although Rh（-）patients should receive red blood cells （RBCs）from Rh（-）donors. The clinical blood transfusion management in Rh（-）patients is controversal until now. Objective We intend to outline a feasible and optimal policy concerning the clinical blood transfusion management in Rh （-）patients based on the currently available evidence. Content This review focuses on the blood transfusion protocols, policy concerning the use of RBCs and the cli nical blood transfusion management including autotransfusion and Rh immunoglobulin in Rh （-）patients. Trend The use of autotransfusion and Rh immunoglobulin will help to improve the clinical blood transfusion management in Rh（-）patients.
出处
《国际麻醉学与复苏杂志》
CAS
2011年第1期75-77,共3页
International Journal of Anesthesiology and Resuscitation
关键词
Rh(一)血
输血管理
Rh（-） blood
Transfusion management
